GSK Reaches ‘First Base’ In Hep B Functional Cure But Has More To Prove

9% Disease Free After Phase II Study

 
• By Andrew McConaghie
Hepatitis B virus
Hepatitis B has so far proven very difficult to suppress - but GSK is hoping to achieve a functional cure for more patients in its Phase III study • Source: Shutterstock

More from Clinical Trials

More from R&D